Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
01/2005
01/27/2005US20050020560 Fusion using acid catalyst
01/27/2005US20050020559 Vision defects; cardiovascular disorders; skin disorders; anticancer agents
01/27/2005DE10329711A1 Verfahren zur Herstellung von alkoxysubstituierten Phthalocyaninen Process for the preparation of alkoxy-substituted phthalocyanines
01/27/2005CA2533100A1 Aryl fused azapolycyclic compounds
01/27/2005CA2532057A1 Novel azaheterocyclic amides useful for treating pain
01/27/2005CA2532013A1 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors; and intermediates thereof
01/27/2005CA2529790A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative
01/26/2005EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors
01/26/2005EP1499898A2 Regulation of tnf-alpha
01/26/2005EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
01/26/2005EP1499614A1 Adenosine a3 receptor modulators
01/26/2005EP1499598A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
01/26/2005EP1499320A1 Novel compounds
01/26/2005EP1499319A1 Bicyclo 4.4.0 antiviral derivatives
01/26/2005EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same
01/26/2005EP1427727B1 Compounds which inhibit the release of inflammatory cytokines
01/26/2005EP1406871A4 Process for the production of n- 3-(3-cyanopyrazolo 1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon)
01/26/2005EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use
01/26/2005EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
01/26/2005CN1571788A Photoactivable nitrogen bases
01/26/2005CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1
01/26/2005CN1569855A Sulfonamide compounds and their production method and use
01/26/2005CN1186326C Propane-1, 3-dione derivatives
01/26/2005CN1186322C Proline derivatives and use thereof as drugs
01/25/2005US6846928 Compositions useful as inhibitors of protein kinases
01/25/2005US6846926 Triazolyl-aminotriazine compositions, including salts
01/25/2005US6846840 Alkylating agents possessing both in vitro cytotoxicity and antitumor activity; for therapy of cancer
01/25/2005US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis
01/25/2005US6846822 Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
01/25/2005US6846819 Bactericides compound containing acrylamide group
01/25/2005CA2191647C Process improvement in the synthesis of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide
01/25/2005CA2174209C Phosphorescent compounds for imaging tissue oxygen
01/20/2005WO2005005571A1 Colour changing media for light emitting display devices
01/20/2005WO2005005551A1 Water-soluble macrocyclic azacalixarenes
01/20/2005WO2005005430A2 Process for the preparation of furopyrroles
01/20/2005WO2005005429A1 Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds
01/20/2005WO2005005428A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
01/20/2005WO2005005427A1 PYRROLO[3,4-c]PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
01/20/2005WO2005005398A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
01/20/2005WO2005005397A1 5-substituted quinazolinone derivatives
01/20/2005WO2005005394A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists
01/20/2005WO2005005392A1 Azacyclic compounds as inhibitors of sensory neurone specific channels
01/20/2005WO2005004808A2 TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS
01/20/2005WO2005004801A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives
01/20/2005WO2005004607A1 Arylmethyl triazolo and imidazopyrazines as c-met inhibitors
01/20/2005WO2004087713A8 Salts of tricyclic inhibitors of poly(adp-ribose) polymerases
01/20/2005US20050014942 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation
01/20/2005US20050014809 Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones
01/20/2005US20050014781 Ring fused pyrazole derivatives as CRF antagonists
01/20/2005US20050014778 Variolin derivatives as anti-cancer agents
01/20/2005US20050014769 Anticancer agents; controlling apoptosis
01/20/2005US20050014759 Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosis
01/20/2005US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction
01/20/2005US20050014756 Process for the preparation of sulphonamide-substituted imidazotriazinones
01/20/2005US20050014755 Tetracyclic compounds as c-Met inhibitors
01/20/2005US20050014754 Anticancer agents; antiinflammatory agents; autoimmune disease
01/20/2005US20050014700 Cbi analogues of cc-1065 and the duocarmycins
01/20/2005DE10320780A1 Heterocyclyl-substituierte Dihydrochinazoline Heterocyclyl-substituted dihydroquinazolines
01/20/2005CA2531759A1 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors
01/20/2005CA2530589A1 Arylmethyl triazolo and imidazopyrazines as c-met inhibitors
01/20/2005CA2530538A1 Thiophenylaminoimidazolines as prostaglandin i2 antagonists
01/20/2005CA2530450A1 5-substituted quinazolinone derivatives
01/20/2005CA2529323A1 Tetracyclic compounds as c-met inhibitors
01/19/2005EP1497296A1 1,4 DIAZOCINO 7,8,1-hi INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
01/19/2005EP1497295A1 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles
01/19/2005EP1497287A1 Quinolinone derivatives
01/19/2005EP1497266A2 Quinoline derivatives and their use as 5-ht6 ligands
01/19/2005EP1497019A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
01/19/2005EP1496940A2 Methods of treating diabetes using pde 11a inhibitors
01/19/2005EP1496910A1 Kinase inhibitors
01/19/2005EP1496907A2 Tyrosine kinase inhibitors
01/19/2005EP1496896A1 Inhibitors of akt activity
01/19/2005EP1381609B1 5-halogen-6-phenyl-7-fluoroalkylamino-triazolopyrimidines as fungicides
01/19/2005EP1368348B1 Novel 2,5-diazabicyclo(2.2.1)heptane derivatives
01/19/2005EP1301515B1 Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
01/19/2005EP1208104B1 Tricyclic inhibitors of poly(adp-ribose) polymerases
01/19/2005CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof
01/19/2005CN1568144A Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
01/19/2005CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
01/19/2005CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use
01/19/2005CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion
01/18/2005US6844444 Photographic cyan coupler; synthetic intermediates
01/18/2005US6844436 Chlorosulfonation, cyclization, salt formation'; impotency; cardiovascular disorders; antidiabetic agents; central nervous system disorders
01/18/2005US6844435 Heterocyclic compounds useful as inhibitors of tyrosine kinases
01/18/2005US6844434 Synthesis of temozolomide and analogs
01/18/2005US6844360 Cellular adhesion molecule and leukointegrin inhibitors; inflammatory diseases; more slowly metabolized
01/18/2005US6844348 2,3,4-cyclopentan-2,3,4-triol-1-yl compounds
01/18/2005US6844345 Piperazine derivatives
01/18/2005US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
01/18/2005US6844341 Cell cycle kinase inhibitors; such as 2-(4-(N-(2-methoxy-ethyl)-sulphamoyl)anilino)-4-(imidazo(1,2b)pyridazin-3 -yl)-pyrimidine
01/18/2005US6844340 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
01/18/2005US6843978 Microporous materials (TIQ-6 and METIQ-6) of high surface area active in oxidation reactions
01/13/2005WO2005003136A1 Rotaxane compound, rotaxane-bonded solid substrate, and biochip using the same
01/13/2005WO2005003135A1 Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
01/13/2005WO2005003134A1 A novel process for the preparation of cilazapril
01/13/2005WO2005003133A2 Method for producing alkoxy-substituted phthalocyanins
01/13/2005WO2005003128A1 Thiazolylpiperidine derivatives as mtp inhibitors
01/13/2005WO2005003102A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase
01/13/2005WO2005003100A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
01/13/2005WO2005002577A1 Dual nk1/nk3 antagonists for treating schizophrenia